Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Jürgen Alt"'
Autor:
Wolfgang M. Brückl, Felix Steger, Jürgen Alt, M. Faehling, Philipp Schütt, Petra Hoffknecht, Anke Schlenska-Lange, Marlitt Horn, Daniel C. Christoph, Christian Schumann, Petros Christopoulos, Stephan Eisenmann
Publikováno v:
Data in Brief
Data in Brief, Vol 34, Iss, Pp 106556-(2021)
Data in Brief, Vol 34, Iss, Pp 106556-(2021)
Following the PACIFIC trial, durvalumab has been approved by the European Medicines Agency (EMA) for consolidation of locally advanced PD-L1-positive NSCLC after chemoradiotherapy (CRT). Patients were treated with durvalumab in the EAP from 22.11.201